DNA-dependent protein kinase and its inhibition in support of radiotherapy

International Journal of Radiation Biology

Volumn 89, Issue 6, 2013, Pages 416-423

  Novotná, Eva ^a   Tichý, Aleš ^a   Pejchal, Jaroslav ^b   Lukášová, Emílie ^c   Šalovská, Barbora ^a   Vávrová, Jiřina ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

DNA PK; DSB; Fractionated irradiation; NHEJ; SiRNA; Small molecule inhibitors

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; SMALL INTERFERING RNA;

CANCER CELL; CANCER THERAPY; DNA END JOINING REPAIR; DNA REPAIR; ENZYME INHIBITION; GAMMA IRRADIATION; HUMAN; IONIZING RADIATION; PRIORITY JOURNAL; RADIOTHERAPY; REVIEW;

ANIMALS; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; HUMANS; NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY;

EID: 84878589114     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2013.767993     Document Type: Review

References (78)

1. An J, Quing-Zhi X, Sui JL, Bai B Zhou PK . 2005. Downregulation of c-myc protein by siRNA-mediated silencing of DNA-PKcs in HeLa cells . International Journal of Cancer 117 : 531 - 537
2. An J, Huang Y, Xu Q, Zhou L, Shang Z, Huang B, Wang Y, Liu X, Wu D, Zhou P . 2010. DNA-PKcs playsádominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression . BMC Molecular Biology 11 : 18
3. Bakkenist CJ, Kastan MB . 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation . Nature 421 : 499 - 506
4. Bardos J, Shea K, Parveen N, Peacock M, Deacon W, Cranston A, Albertella M, Menear K, Smith G, Martin N . 2009. Radio- and chemosensitization through inhibition of DNA-PK by KU0060648 . Molecular Cancer Th erapy 8:A 116
5. Bartek J, Bartkova J, Lukas J . 2007. DNA damage signalling guards against activated oncogenes and tumour progression . Oncogene 26 : 7773 - 7779
6. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, Lukas J . 2006. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks . Journal of Cell Biology 173 : 195 - 206
7. Bekker-Jensen S, Mailand N . 2010. Assembly and function of DNA double-strand break repair foci in mammalian cells . DNA Repair 9 : 1219 - 1228
8. Bennett CB, Lewis AL, Baldwin KK, Resnick MA . 1993. Lethality induced byá1017 single site-speci fi c double-strand break iná dispensableýeast plasmid, 1018 . Proceedings of the National Academy of Sciences of the USA 90 : 5613 - 5617
9. Bogue MA, Jhappan C, Roth DB . 1998. Analysis of variable (diversity) joining recombination in DNA-dependent protein kinase (DNAPK)- defi cient mice reveals DNA-PK independent pathways for both signal and coding joint formation . Proceedings of the National Academy of Sciences of the USA 95 : 15559 - 15564
10. Boyer J, Rohleder K, Ketner G . 1999. The adenovirus early region 434 kDa and 11kDa oncoproteins inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase . Virologý 263 : 307 - 312
11. Boyle P, Levin B . 2008 . World cancer report 2008 . Lyon: International Agency for Research on Cancer; Geneva: Distributed by WHO Press
12. Burdak-Rothkamm S, Prise KM . 2009. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and nontargeted cells . European Journal of Pharmacology 625: 151- 155
13. Cano C, Barbeau OR, Bailey Ch, Cockcroft X-L, Curtin NJ, Duggan H, Frigerio M, Golding BT, Hardcastle IR, Hummersone MG, Knights Ch, Menear KA, Newell DR, Richardson CJ, Smith GCM, Spittle B, Griffi n RJ . 2010. DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of Quinolin-4-one and Pyridopyrimidin-4-one surrogates for the Chromen-4-one chemotype . Journal of Medicinal Chemistry 53 : 8498 - 8507
14. Chan DW, Lees-Miller S . 1996 . The DNA-dependent protein kinase is inactivated by autophosphorylation of the catalytic subunit . The Journal of Biological Chemistry 271 : 8936 - 8941
15. Cheng JC, Moore TB, Sakamoto KM . 2003. RNA interference and human disease . Molecular Genetics and Metabolism 80: 121- 128
16. Clapham KM, Bardos J, Finlay MRV, Golding BT, Griff en EJ, Griffi n RJ, Hardcastle IR, Menear KA, Ting A, Turner P,ýoung GL, Cano C . 2011 DNA-dependent protien kinase (DNA-PK) inhibitors: Structureactivity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domain. Bioorganic & Medicinal Chemistry Letters 21 : 966 - 970
17. Collis JS, DeWeese TL, Jeggo AP, Parker AR . 2005 . The live and death of DNA-PK . Oncogene 24 : 949 - 961
18. DiBiase S, Zeng ZCH, Chen R, Hyslop T, Curran WJ, Iliakis G . 2000 DNA-dependent protein kinase stimulates an independently active nonhomologous end-joining apparatus . Cancer Research 60 : 1245 - 1253
19. Dobbs TA, Tainer JA, Lees-Miller S . 2010.ástructural model for regulation of NHEJ by DNA-PKcs autophosphorylation . DNA Repair 9 : 1307 - 1314
20. Dutreix M, Cosset JM, Sun JS . 2010. Molecular therapy in support to radiotherapy. Mutation Research 704: 182- 189
21. Elbashir SM, Harborth J, Lendeckel W,ýalcin A, Weber K, Tuschl T. 2001 . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells . Nature 411 : 494 - 98
22. Fattah KR, Ruis BL, Hendrickson EA . 2008. Mutations to Ku reveal diff erences in human somatic cell lines . DNA Repair 7: 762- 764
23. Fuhrman CB, Kilgore J, LaCoursiereýD, Lee CM, Milash BA, Soisson AP, Zempolich KA . 2008. Radiosensitization of cervical cancer cells via double-strand DNA break repair inhibition . Gynecologic Oncology 110 : 93 - 98
24. Galanis E, Vile R, Russell SJ . 2001 . Delivery systems intended for in vivo gene therapy of cancer: Targeting and replication competent viral vectors . Critical Reviews in Oncology/Hematology 38: 177- 192
25. Gupta AK, Cerniglia GJ, Mick R, Ahmed MS, Bakanauskas VJ, Muschel RJ, McKenna WG . 2003. Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002 International Journal of Radiation Oncology Biology Physics 56 : 846 - 853
26. Hammel M,ýu Y, Mahaney BL, Cai B,ýe R, Phipps BM, Rambo RP, Hura GL, Pelikan M, So S, Abolfath RM, Chen DJ, Lees-Miller SP, Tainer JA . 2010 . Ku and DNA-dependent protein kinase dynamic conformations and assembly regulate DNA binding and the initial non-homologous end joining complex . The Journal of Biological Chemistry 285 : 1414 - 1423
27. Hardcastle IR, Cockroft X, Curtin NJ, et al. 2005. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) usingásmall-molecule library approach . Journal of Medicinal Chemistry 48 : 7829 - 7846
28. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC . 2004. Identifi cation and characterization ofánovel and specifi c inhibitor of the Ataxiatelangiectasia mutated kinase ATM. Cancer Research 64: 9152- 9159
29. Hill R, Lee PWK . 2010. The DNA-dependent protein kinase (DNA-PK): More than justácase of making ends meet? Cell Cycle 9 : 3460 - 3469
30. Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terzoudi G, Pantelias G . 2004. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenetic and Genome Research 104 : 14 - 20
31. Iliakis G . 2009. Backup pathways of NHEJ in cells of higher eukaryotes: Cell cycle dependence . Radiotherapy and Oncology 92: 310- 315
32. Jeggo P, Lavin MF . 2009 . Cellular radiosensitivity: How much better do we understand it? International Journal of Radiation Biology 85 : 1061 - 1081
33. Jeggo PA . 1998. Identifi cation of genes involved in repair of DNA doublestrand breaks in mammalia cells . Radiation Research 150: 80- 91
34. Jiang H, Reinhardt CH, Bartkova J, Tommiska J, Blomqvist C, Nevanlinna H, Bartek J,ýaff e MB, Hemann MT . 2010. The combined status of ATM and p53 link tumour development with therapeutic response . Genes Development 23: 1895- 1909
35. Kim C, Park S, Lee S . 2002.átargeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation . The Journal of Pharmacology and Experimental Th erapeutics 303: 753- 759
36. Mao Z, Bozzella M, Seluanov A, Gorbunova V . 2008. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells . Cell Cycle 7: 2902- 2906
37. Marcon E, Moens PB . 2005 . The evolution of meiosis: Recruitment and modifi cation of somatic DNA-repair proteins . BioEssays 27 : 795 - 808
38. Martin NMB . 2001. DNA repair inhibition and cancer therapy. Journal of Photochemistry and Photobiology 63: 162- 170
39. Mikusova V, Tichý A, Řeza čováM, VávrováJ . 2011. Mitoxantrone in combination witháDNA-PK inhibitor: Possible therapy of promyelocytic leukaemia resistant forms . Folia Biologica (Praha) 57: 200- 205
40. Muller C, Christodoupoulos G, Salles B, Panasci L . 1998 . DNA-dependent protein kinase activity correlates with clinical and in vitro senzitivity of chronic lymphocytic leukaemia lymphocytes to nitrogen mustards . Blood 92 : 2213 - 2219
41. Munck JM, Batey MA, Zhao Y, Jenkins H, Richardson CJ, Cano C, Tavecchio M, Barbeau J, Bardos J, Cornell L, Griffi n RJ, Menear K, Slade A, Th ommes P, Martin NMB, Newell DR, Smith GC, Curtin NJ . 2012. Chemosensitization of cancer cells by KU-0060648,ádual inhibitor of DNA-PK and PI-3K . Molecular Cancer Th erapeutics 11:1789-98
42. Neal JA, Meek K . 2011. Choosing the right path: Does DNA-PK help the decision? Mutation Research 711: 73- 86
43. Nutley BP, Smith NF, Hayes A, Kelland LR, Brunton L, Golding BT, Smith GCM, Martin NBM, Workman P, Raynaud FI . 2005. Preclinical pharmacokinetics and metabolism ofánovel prototype DNA-PK inhibitor NU7026 . British Journal of Cancer 93 : 1011 - 1018
44. Pawelczak KS, Turchi JJ . 2010 . Purifi cation and characterization of exonuclease- free Artemis: Implications for DNA-PK-dependent processing of DNA termini in NHEJ-catalyzed DSB repair . DNA Repair 9 : 670 - 677
45. Payne SL, Rodriguez-Aristegui S, Bardos J, Cano C, Golding BT, Hardcastle IR, Peacock M, Parveen N, Griffi n RJ . 2010. Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors . Bioorganic & Medicinal Chemistry Letters 20 : 3649 - 3653
46. Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, Bedford JS . 2002. Silencing Expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Research 62: 6400- 6404
47. Quanz M, Chassoux D, Berthault N, Agrario C, Sun JS, Dutreix M. 2009a . Hyperactivation of DNA-PK by double-strand break mimicking molecules disorganizes DNA damage response . Public Library of Science One 4 : E6298
48. Quanz M, Berhault N, Roulin C, Roy M, Herbette A, Agrario C, Alberti C, Josserand V, Coll JL, Sastre-Garau X, Cosset JM, Larue L, Sun JS, Dutreix M . 2009b . Small-molecule drugs mimicking DNA-damage: Ánew strategy for sensitizing tumours to radiotherapy . Clinical Cancer Research 15: 1308- 1316
49. Rainey MD, Charlton ME, Stanton RV, Kastan MB . 2008 . Transient inhibition of ATM kinase is suffi cient to enhance cellular sensitivity to ionizing radiation. Cancer Research 68: 7466- 7474
50. Rao DD, Vorhies JS, Senzer N, Nemunaitis J . 2009. siRNA vs. shRNA: Similarities and diff erences . Advanced Drug Delivery Reviews 61 : 746 - 759
51. Rube CE, Fricke A, Wendorf J, Stutzel A, Kuhne M, Ong MF, Lipp P, Rube CH . 2010 . Accumulation of DNA double-strand breaks in normal tissues after fractionated irradiation . International Journal of Radiation Oncology Biology Physics 76: 1206- 1213
52. Řeza čováM, Rudolfova G, Tichý A, Ba čikova A, MuthnáD, Havelek R, VávrováJ, Odrážka K, LukášováE, Kozubek S . 2011 . Accumulation of DNA damage and cell death after fractionated irradiation . Radiation Research 175: 708- 718
53. Saravanan K, Albertella M, Cano C, Curtin NJ, Frigerio M, Golding BT, Haggerty K, Hardcastle IR, Hummersone M, Menear K, Newell DR, Rennison T, Richardson C, Rigoreau L, Rodriguez-Aristegui S, Smith GCM, Griffi n RJ . 2008. Identifi cation of potent water-soluble DNA-dependent protein kinase (DNA-PK) inhibitors usingásmall-molecule library approach . In: Proceedings of the 99th Annual Meeting of the American Association for Cancer Research San Diego, CA: AACR
54. Sarkaria JN, Tibbets RS, Busby EC, Kennedy AP, Hill DE, Abraham RT. 1998 . Inhibition of phosphoinositide 3-kinase elated kinases by the radiosensitizing agent wortmannin. Cancer Research 58: 4375- 4382
55. Sarkaria JN, Busby EC, Tibbets RS, Roos P, Taya Y, Karnitz LM, Abraham RT . 1999 . Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caff eine . Cancer Research 59: 4375- 4382
56. Senra JM, Tefl er BA, Cherry KE, McCrudden CM, Hirst DG, O'Connor MJ, Wedge SR, Stradford IJ . 2011. Inhibition of poly(ADP-ribose) polymerase-1 by olaparib (AZD2281) increases the radiosensitivity ofálung tumour Xenograft . Molecular Cancer Th erapeutics 10 : 1949 - 1958
57. Shimura T, Kakuda S, Ochiai Y, Nagakawa H, Kuwahara Y, Takai Y, Kobayashi J, Komatsu K, Fukumoto M . 2010. Acquired radioresistance of human tumour cells by DNA-PK/AKT/GSK3 ® -mediated cyclin D1 overexpression. Oncogene 29: 4826- 4837
58. Stein RC . 2005 . Prospect for phosphoinositide 3-kinase inhibition asácancer treatment endocrine-related cancer . Radiosensitisation and Radiotheraphy Oncology 74: 117- 129
59. SzkanderováS, VávrováJ, Řeza čováM, VokurkováD, PavlováS, SmardováJ, Stulik J . 2003. Gamma irradiation results in phosphorylation of p53 at serine-392 in human T-lymphocyte leukaemia cell line MOLT-4. Folia Biologia (Praha) 49: 191- 196
60. Takata M, Sasaki MS, Sonoda E, Morrison C,ýamaguchi-Iwai Y, Shinohara A, Takeda S . 1998. Homologous recombination and nonhomologous end joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. E MBO Journal 1 7: 5 497- 5 508
61. Tichý A, Záškodova D, Řeza čováM, VávrováJ, VokurkováD, Pejchal J, VilasováZ, Cerman J, Ossterreicher J . 2007. Gamma-radiation-induced ATM-dependent signalling in human T-lymphocyte leukemic cells, MOLT-4. Acta Biochimica Polonica 54: 281- 287
62. Tichý A, Záškodova D, VávrováJ, Pejchal J, Řeza čováM . 2011. Caff einesuppressed ATM pathway leads to decreased p53 phosphorylation and increased programmed cell death in gamma-irradiated leukaemic MOLT-4 cells. J ournal of Applied Biomedicine 9 : 4 9- 5 6
63. Tichý A, NovotnáE, Ďuri ŠováK, ŠalovskáB, Sedla řikova R, Pejchal J, Z arybnicka L, VávrováJ, ŠinkorováZ, Řezacova M . 2012. Radiosensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7026 . Acta Medica 55 : 66 - 73
64. Valerie K, Povirk LF . 2003 . Regulation and mechanisms of mammalian double-strand break repair . Oncogene 22 : 5792 - 5812
65. Van der Burg M, Ijspeert H, Verkaik RS, Turul T, et al. 2009.áDNA-PKcs mutation ináradiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining . Journal of Clinical Investigation 119: 91- 98
66. VávrováJ, Marekova- Řeza čováM, VokurkováD, SzkanderováS, Psutka J . 2003. Caff eine inducesásecond wave of apoptosis after low dose-rate gamma radiation of HL-60 cells . Radiation and Environmental Biophysics 42 : 193 - 199
67. Veuger SJ, Curtin NJ, Richardson CJ, et al. 2003. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose)polymerase 1. Cancer Research 63: 6008- 6015
68. Vilasov á Z, Ř ezačov á M, Vavrov á J, Tichý́ A, Vokurkov á D . 2008. Changes in phosphorylation of histone H2A.X and p53 in response of peripheral blood lymphocytes to gamma irradiation . Acta Biochimica Polonica 55 : 381 - 90
69. Vilenchik MM, Knudson AG . 2003 . Endogenous DNA double-strand breaks: Production, fi delity of repair, and induction of cancer. Proceedings of the National Academy of Sciences of the USA 100 : 12871 - 12876
70. Vlahos CJ, Matter WF, Hui KY, Brown RF . 1994.áspecifi c inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002) . Journal of Biological Chemistry 269 : 5241- 5248
71. Wang H, Zeng ZC, Perrault AR, Cheng X, Qin W, Iliakis G . 2001. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK dependent pathway of non-homologous end joining in mammalian cells. Nucleic Acids Research 29: 1653- 1660
72. Wang Y, Ghosh G, Hendrickson EA . 2009. Ku86 represses lethal telomere events in human somatic cells . Proceedings of the National Academy of Sciences of the USA 106 : 12430 - 12435
73. White JS, Choi S, Bakkenist CJ . 2008. Irreversible chromosome damage accumulates rapidly in the absence of ATM kinase activity . Cell Cycle 7 : 1277 - 1284
74. White JS, Choi S, Bakkenist CJ . 2010 . Transient ATM kinase inhibition disrupts DNA damage-induced sister chromatid exchange . Science Signalling 3: Ra44
75. Willmore E, de Caux S, Sunter NJ, Tilby MJ, Jackson GH, Austin CA, Durkacz BW . 2004.ánovel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukaemia . Blood 103 : 4659 - 4665
76. ýan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo Y, Mao H, Hao C, Olson JJ, Curran WJ, Wangý . 2010. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumours to radiation. PLoS ONE 5: E11397
77. Zhang J, Zhou J, Cao X, Zhang Q, Lim CHUK, Ullrich R, Bailey SM, Liber HL . 2007 . Partial defi ciency of DNA-PKcs increases ionizing radiation- induced mutagenesis and telomere instability in human cells. Cancer Letters 250 : 63 - 73
78. Zhao Y, Huw DT, Batey MA, Cowell IG, Richardson CJ, Griffi n RJ, Calvert AH, Newell DR, Smith GCM . 2006. Preclinical evaluation ofápotent novel DNA-dependent protein kinase inhibitor NU7441 . Cancer Research 66: 5354- 5362.